Internal Medicine Doctors in Kingston, PA Accepting Medicare

26 Internal Medicine doctors found. Showing 21 - 26

Javid Rohullah Amini, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 610 Wyoming Ave, Suite 1, Kingston, PA 18704 Phone: 570-288-5441    Fax: 570-288-9613

Lorraine Riotto, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 382 Pierce St, Kingston, PA 18704 Phone: 570-288-7231    Fax: 570-331-4616

Jacqueline Cain, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 Wyoming Ave, Suite 2, Kingston, PA 18704 Phone: 570-288-6627    Fax: 570-288-6699

Dr. Mark George Evans, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 499 Wyoming Ave, Kingston, PA 18704 Phone: 570-714-3050    Fax: 570-714-3055

Richard D Michelstein, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 610 Wyoming Ave, Suite 1, Kingston, PA 18704 Phone: 570-288-5441    Fax: 570-288-9613

Bradley D Fenster, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 610 Wyoming Ave, Kingston, PA 18704 Phone: 570-283-5806    Fax: 570-283-5807

News Archive

Study suggests better quality primary care improves health

Financial incentives in primary care cut heart disease deaths and hospital admissions, particularly among people from deprived areas, finds research published online in the Journal of Epidemiology and Community Health.

Study reveals mechanism behind male infertility caused by autoimmune disease

Investigators have found that the absence of autoimmune regulator (Aire) in mice results in fertility problems similar to those affecting men with autoimmune polyendocrine syndrome type I (APS-1).

Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today the availability of its ResponseDX: Gastric™ genetic test panel, a proprietary PCR-based diagnostic test. By analyzing the expression of genes that correlate with response to commonly used chemotherapy agents, physicians can better tailor treatment for their patients with gastric cancer and gastroesophageal (GE) junction cancer.

Nutranomics releases results of human patient clinical studies regarding Glucozyme

Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the results of human patient clinical studies undertaken by the Company regarding Glucozyme™ are nearing a public release date.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)